Diabetic kidney disease, also known as diabetic nephropathy, is a chronic condition caused due to long-term poorly controlled diabetes. It mainly develops as a complication of type 1 and 2 diabetes and is a leading cause of kidney failure. The increasing prevalence of diabetes globally is driving demand for treatment options such as antihypertensive medications, ACE inhibitors, Angiotensin II receptor blockers, and SGLT2 inhibitors which help slow down the progression of kidney damage.

The Global Diabetic Kidney Disease Market is estimated to be valued at US$ 4.21 Bn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in The Diabetic Kidney Disease Market are AstraZeneca, Boehringer Ingelheim, Janssen Pharmaceuticals, Bristol Myers Squibb, GSK, Novo Nordisk, Eli Lilly and Company, Merck & Co., Sanofi, AbbVie, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Lupin, Aurobindo Pharma, Takeda Pharmaceutical Company Limited, Biogen, Vertex Pharmaceuticals Incorporated. The companies are focusing on developing new drugs and combination therapies for better treatment outcomes.

The key opportunities in the market include growing awareness about diabetes management, increasing healthcare expenditure, and launch of new treatment guidelines. Several clinical trials are being conducted to evaluate new molecules for Diabetic Kidney Disease. Advancements in target specific drug therapies such as SGLT2 inhibitors are expected to drive significant growth in the market.

Market drivers:

The growing elderly population with diabetes and rising obesity and unhealthy lifestyles increasing the risk of diabetes are some of the key factors driving the growth of the Diabetic Kidney Disease Market Share. According to estimates, nearly 1 in 3 Americans is expected to develop some form of chronic kidney disease due to diabetes by 2030. Stringent regulatory guidelines regarding the labelling and marketing of anti-diabetic drugs will also promote the development of safer and more effective treatment options.

Get more insights on Diabetic Kidney Disease Market